RedHill Biopharma Ltd. (RDHL)

USD 2.07

(-3.72%)

Revenue Summary of RedHill Biopharma Ltd.

  • RedHill Biopharma Ltd.'s latest annual revenue in 2023 was 6.51 Million USD , down -89.46% from previous year.
  • RedHill Biopharma Ltd.'s latest quarterly revenue in 2023 FY was 6.51 Million USD , down -89.46% from previous quarter.
  • RedHill Biopharma Ltd. reported a annual revenue of 61.8 Million USD in annual revenue 2022, down -27.94% from previous year.
  • RedHill Biopharma Ltd. reported a annual revenue of 85.75 Million USD in annual revenue 2021, up 33.25% from previous year.
  • RedHill Biopharma Ltd. reported a quarterly revenue of 3.59 Million USD for 2023 Q1, down -71.88% from previous quarter.
  • RedHill Biopharma Ltd. reported a quarterly revenue of 6.51 Million USD for 2023 FY, down -89.46% from previous quarter.

Annual Revenue Chart of RedHill Biopharma Ltd. (2023 - 2010)

Historical Annual Revenue of RedHill Biopharma Ltd. (2023 - 2010)

Year Revenue Revenue Growth
2023 6.51 Million USD -89.46%
2022 61.8 Million USD -27.94%
2021 85.75 Million USD 33.25%
2020 64.35 Million USD 923.03%
2019 6.29 Million USD -24.75%
2018 8.36 Million USD 108.63%
2017 4 Million USD 3867.33%
2016 101 Thousand USD 3266.67%
2015 3000.00 USD -99.96%
2014 7.01 Million USD 58350.0%
2013 12 Thousand USD -25.0%
2012 16 Thousand USD -30.43%
2011 23 Thousand USD 0.0%
2010 - USD 0.0%

Peer Revenue Comparison of RedHill Biopharma Ltd.

Name Revenue Revenue Difference
Esperion Therapeutics, Inc. 116.33 Million USD 94.401%
Theratechnologies Inc. 81.76 Million USD 92.034%
Safety Shot Inc 202.67 Thousand USD -3113.684%
Cosmos Health Inc. 53.37 Million USD 87.798%
Cronos Group Inc. 88.84 Million USD 92.669%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 98.529%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Organogenesis Holdings Inc. 433.14 Million USD 98.496%
Universe Pharmaceuticals INC 32.3 Million USD 79.841%
ProPhase Labs, Inc. 44.38 Million USD 85.325%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD 48.856%
Dynavax Technologies Corporation 232.28 Million USD 97.196%
Radius Health, Inc. 2.88 Billion USD 99.774%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -237.733%
Alvotech 91.43 Million USD 92.877%
Sunshine Biopharma, Inc. 24.09 Million USD 72.966%
Alpha Teknova, Inc. 36.68 Million USD 82.245%
Intra-Cellular Therapies, Inc. 464.37 Million USD 98.597%
SCYNEXIS, Inc. 140.14 Million USD 95.352%
Harrow Health, Inc. 130.19 Million USD 94.997%
Biofrontera Inc. 34.07 Million USD 80.884%
DURECT Corporation 8.54 Million USD 23.805%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 98.928%
ANI Pharmaceuticals, Inc. 486.81 Million USD 98.662%
OptiNose, Inc. 70.98 Million USD 90.825%
Aquestive Therapeutics, Inc. 50.58 Million USD 87.124%
Cumberland Pharmaceuticals Inc. 39.55 Million USD 83.533%
SIGA Technologies, Inc. 139.91 Million USD 95.345%
Lifecore Biomedical, Inc. 128.26 Million USD 94.922%
Shineco, Inc. 9.8 Million USD 33.552%
Phibro Animal Health Corporation 1.01 Billion USD 99.36%
Procaps Group S.A. 409.92 Million USD 98.411%
TherapeuticsMD, Inc. 1.3 Million USD -400.244%
Regencell Bioscience Holdings Limited - USD -Infinity%
Viatris Inc. 15.42 Billion USD 99.958%
Sunshine Biopharma, Inc. 24.09 Million USD 72.966%
Rockwell Medical, Inc. 83.61 Million USD 92.21%
Incannex Healthcare Limited 12 Thousand USD -54176.442%
Aytu BioPharma, Inc. 81 Million USD 91.959%
Tilray Brands, Inc. 788.94 Million USD 99.174%
Collegium Pharmaceutical, Inc. 566.76 Million USD 98.851%
PetIQ, Inc. 1.1 Billion USD 99.409%
Silver Spike Investment Corp. 11.72 Million USD 44.437%
Neurocrine Biosciences, Inc. 1.88 Billion USD 99.655%
Journey Medical Corporation 79.18 Million USD 91.774%
Alimera Sciences, Inc. 80.75 Million USD 91.935%
Petros Pharmaceuticals, Inc. 5.82 Million USD -11.864%
Assertio Holdings, Inc. 152.06 Million USD 95.717%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Embecta Corp. 1.12 Billion USD 99.419%
Cyclo Therapeutics, Inc. 1.07 Million USD -505.086%
Procaps Group, S.A. 409.92 Million USD 98.411%
PainReform Ltd. - USD -Infinity%
Avadel Pharmaceuticals plc 27.96 Million USD 76.708%
Hempacco Co., Inc. 4.04 Million USD -60.993%
Talphera, Inc. 651 Thousand USD -900.487%
Pacira BioSciences, Inc. 674.97 Million USD 99.035%
Alvotech 91.43 Million USD 92.877%
Lantheus Holdings, Inc. 1.29 Billion USD 99.498%
Kamada Ltd. 144.75 Million USD 95.501%
Indivior PLC 1.09 Billion USD 99.404%
Currenc Group, Inc. 53.25 Million USD 87.77%
Evoke Pharma, Inc. 5.18 Million USD -25.722%
Flora Growth Corp. 76.07 Million USD 91.438%
Cyclo Therapeutics, Inc. 1.07 Million USD -505.086%
Evolus, Inc. 202.08 Million USD 96.777%
HUTCHMED (China) Limited 837.99 Million USD 99.223%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 98.989%
Akanda Corp. 2.16 Million USD -201.529%